State Of Wyoming Neuronetics, Inc. Transaction History

State Of Wyoming

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$2.81 - $6.71 $12,541 - $29,946	-4,463 Reduced 9.94%	40,435 $117,000
Q4 2022 Feb 14, 2023	BUY	$3.44 - $6.87 $2,738 - $5,468	796 Added 1.8%	44,898 $308,000
Q3 2022 Nov 14, 2022	BUY	$2.35 - $4.66 $103,639 - $205,515	44,102 New	44,102 $140,000
Q1 2022 May 13, 2022	SELL	$2.84 - $4.52 $49,921 - $79,452	-17,578 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$3.87 - $6.59 $24,535 - $41,780	6,340 Added 56.42%	17,578 $78,000

Q3 2021 Feb 11, 2022	BUY	$6.22 - $15.54 $65,776 - $164,335	10,575 Added 1595.02%	11,238 $74,000
Q2 2021 Feb 11, 2022	BUY	$10.15 - $17.25 $6,729 - $11,436	663 New	663 $11,000

18.4M

200

3.6K

Ticker STIM
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,022,800
Market Cap $47.3M
Description
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.